Rising Operating Costs And Regulation Will Squeeze Long-Term Potential
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 10 Analysts
Published
11 May 25
Updated
23 Jul 25
AnalystLowTarget's Fair Value
US$38.00
14.0% overvalued intrinsic discount23 Jul
US$43.32
1Y
-3.4%7D
3.7%